DexCom Aktie
75,87
EUR
+3,29
EUR
+4,53
%
79,15
USD
-0,39
USD
-0,49
%
DexCom Aktie Analyse
02.08.18 | DexCom Buy | Canaccord Adams | |
03.05.18 | DexCom Buy | Canaccord Adams | |
23.03.18 | DexCom Outperform | Robert W. Baird & Co. Incorporated | |
28.09.17 | DexCom Outperform | Wedbush Morgan Securities Inc. | |
03.05.17 | DexCom Buy | Canaccord Adams | |
02.11.16 | DexCom Buy | Canaccord Adams | |
24.02.16 | DexCom Buy | The Benchmark Company | |
06.08.15 | DexCom Buy | Canaccord Adams | |
Werbung
|
|||
08.07.15 | DexCom Outperform | Robert W. Baird & Co. Incorporated | |
24.10.06 | DexCom Outperform | Piper Jaffray |